Labelling Review row-Online
Labelling Review row-Online
Labelling Review row-Online
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Human benign nodular hyperplasia of prostate: immunohistochemical staining for cytokeratins<br />
using RTU-AE1/AE3. Note intense cytoplasmic staining of glandular myoepithelial cells.<br />
Paraffin section.<br />
Multi-Cytokeratin (4/5/6/8/10/13/18)<br />
Clone C-11<br />
1 mL lyophilized NCL-C11 F P (HIER)<br />
Cytokeratins 4, 5, 6, 8, 10, 13 and 18 are differentially expressed between a<br />
variety of normal, reactive and neoplastic epithelia and also simple<br />
epithelium and both basal and suprabasal layers of cornifying and noncornifying<br />
squamous epithelium.<br />
NCL-C11 is reported to react with human cytokeratins 4, 5, 6, 8, 10, 13 and 18.<br />
Multi-Cytokeratin 1/5/10/14<br />
Clone 34�E12<br />
1 mL lyophilized NCL-CK34BE12 F P (HIER) W<br />
7 mL ready-to-use RTU-CK34BE12 F P (HIER)<br />
7 mL Bond ready-to-use PA0134 P (Enzyme)<br />
NCL-CK34�E12 reacts with human cytokeratin intermediate filament<br />
proteins 1, 5, 10 and 14. The antibody is reported to react with squamous<br />
epithelium and sweat ducts in normal skin, some pneumocytes, bronchial<br />
epithelium and mesothelium in normal lung and bile ducts in normal liver. It<br />
also reacts with ductal cells of the normal pancreas, some acinar and ductal<br />
cells of normal breast, some follicular epithelia of normal thyroid and some<br />
epithelia and mesothelium of the normal small and large bowel.<br />
Refer to page 27 for the Bond ready-to-use format.<br />
Multi-Cytokeratin (5/6/8/18)<br />
5D3, Clone LP34<br />
1 mL, 0.1 mL lyophilized NCL-CK5/6/8/18 F P (Enzyme)<br />
1 mL liquid NCL-L-CK5/6/8/18 F P (Enzyme)<br />
7 mL ready-to-use RTU-CK5/6/8/18 F P (Enzyme)<br />
Product Specific Information<br />
NCL-CK5/6/8/18, NCL-L-CK5/6/8/18 and RTU-CK5/6/8/18 react with human<br />
cytokeratins 5, 6, 8 and 18. These products are cocktails of monoclonal<br />
antibodies designed to recognize cytokeratins reported to be expressed in<br />
almost all epithelial tissues.<br />
Human squamous cell carcinoma of the floor of the mouth: immunohistochemical staining for<br />
cytokeratins using NCL-L-CK5/6/8/18. Note intense cytoplasmic staining of malignant cells.<br />
Paraffin section.<br />
Multidrug Resistance-Associated<br />
Protein Antibodies<br />
Clone 33A6<br />
1 mL, 0.1 mL lyophilized Multidrug Resistance-associated<br />
Protein 1 NCL-MRP1 P (HIER)<br />
Clone DTX1<br />
1 mL lyophilized Multidrug Resistance-associated<br />
Protein 3 NCL-MRP3 P (HIER)<br />
The human multidrug resistance-associated protein (MRP) gene family<br />
contains at least 6 members designated MRP1 to 6. MRP1 is a<br />
phosphoprotein of 1531 amino acids and is expressed in a variety of cell<br />
types. MRP1 mRNA has been demonstrated in lung, testis and peripheral<br />
blood mononuclear cells but was not detected in placenta, brain, salivary<br />
gland, liver, uterus and spleen. The protein has been expressed in the<br />
epithelium and glands of nasal respiratory mucosa. MRP3 is a 190 to 200 kD<br />
integral membrane protein which is an organic anion transporter effective in<br />
transporting chemotherapeutic drugs such as MTX, etoposide and<br />
teniposide. Northern blotting of various human tissues has indicated MRP3<br />
to be expressed in liver, colon, pancreas and at lower levels in the kidney.<br />
MRP5 mRNA is reported to be expressed in almost all tissues, especially<br />
skeletal muscle and brain with lower expression observed in liver, adrenal<br />
gland, placenta, ovary and pancreas.<br />
Human ovary: immunohistochemical staining for multidrug resistance-associated protein 1<br />
using NCL-MRP1. Note cytoplasmic staining of granulosa and thecal cells. Paraffin section.<br />
F Frozen I Immunofluorescence E Electron microscopy<br />
P Paraffin C Flow cytometry O Other applications<br />
W Western blotting<br />
/ 137<br />
Primary Antibodies